Publicacións nas que colabora con Felipe Fernández Vázquez (34)

2022

  1. A Score to Assess Mortality After Percutaneous Mitral Valve Repair

    Journal of the American College of Cardiology, Vol. 79, Núm. 6, pp. 562-573

  2. Center Valve Preference and Outcomes of Transcatheter Aortic Valve Replacement: Insights From the AMTRAC Registry

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 12, pp. 1266-1274

  3. Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction

    European heart journal, Vol. 43, Núm. 7, pp. 641-650

  4. Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality

    European Journal of Heart Failure, Vol. 24, Núm. 11, pp. 2175-2184

  5. Procedural and clinical outcomes after repeat edge-to-edge transcatheter mitral valve repair

    Catheterization and Cardiovascular Interventions, Vol. 99, Núm. 5, pp. 1619-1625

  6. Prognostic Impact of Nutritional Status After Transcatheter Edge-to-Edge Mitral Valve Repair: The MIVNUT Registry

    Journal of the American Heart Association, Vol. 11, Núm. 20

  7. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  8. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

  9. Temporal trend and potential impact of angiotensin receptor neprilysin inhibitors on transcatheter edge-to-edge mitral valve repair

    Revista Espanola de Cardiologia, Vol. 75, Núm. 12, pp. 1001-1010

2020

  1. Transcatheter Treatment of Residual Significant Mitral Regurgitation Following TAVR: A Multicenter Registry

    JACC: Cardiovascular Interventions, Vol. 13, Núm. 23, pp. 2782-2791

  2. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation

    Journal of the American Medical Directors Association, Vol. 21, Núm. 3, pp. 367-373.e1